169 related articles for article (PubMed ID: 11979129)
1. Streptococcus pneumoniae respiratory tract infections.
Klugman KP; Feldman C
Curr Opin Infect Dis; 2001 Apr; 14(2):173-9. PubMed ID: 11979129
[TBL] [Abstract][Full Text] [Related]
2. [Increasing antibiotic resistance of pneumococcus. Management of respiratory tract infections and meningitis].
Kalin M; Eriksson M; Mölstad S; Prellner K
Lakartidningen; 1997 Mar; 94(12):1061-4, 1067-8. PubMed ID: 9121238
[No Abstract] [Full Text] [Related]
3. Update on pneumococcal infections of the respiratory tract.
Tan TQ
Semin Respir Infect; 2002 Mar; 17(1):3-9. PubMed ID: 11891513
[TBL] [Abstract][Full Text] [Related]
4. [A new antibiotic against respiratory tract infections. More power against pneumococci].
MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
[No Abstract] [Full Text] [Related]
5. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
Nuermberger EL; Bishai WR
Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371
[TBL] [Abstract][Full Text] [Related]
6. The clinical impact of macrolide resistance in pneumococcal respiratory infections.
Garau J
Int J Antimicrob Agents; 2001; 18 Suppl 1():S33-8. PubMed ID: 11574193
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
Jacobs MR
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
[TBL] [Abstract][Full Text] [Related]
8. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
Fuller JD; Low DE
Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistant infections due to Streptococcus pneumoniae: impact on therapeutic options and clinical outcome.
Tan TQ
Curr Opin Infect Dis; 2003 Jun; 16(3):271-7. PubMed ID: 12821820
[TBL] [Abstract][Full Text] [Related]
10. [Discussions on PRSP and BLNAR].
Tajima T; Meguro H; Akita H; Iwata T
Jpn J Antibiot; 2001 May; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161
[No Abstract] [Full Text] [Related]
11. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.
Gordon KA; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2003 Aug; 46(4):285-9. PubMed ID: 12944021
[TBL] [Abstract][Full Text] [Related]
12. Hidden epidemic of macrolide-resistant pneumococci.
Klugman KP; Lonks JR
Emerg Infect Dis; 2005 Jun; 11(6):802-7. PubMed ID: 15963272
[TBL] [Abstract][Full Text] [Related]
13. The in vivo-in vitro paradox in pneumococcal respiratory tract infections.
Bishai W
J Antimicrob Chemother; 2002 Mar; 49(3):433-6. PubMed ID: 11864942
[No Abstract] [Full Text] [Related]
14. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance patterns and serotype distribution in Streptococcus pneumoniae from hospitalized pediatric patients with respiratory infections in Suzhou, China.
Chen R; Chen Y; Black S; Hao CL; Ding YF; Zhang T; Zhao GM
J Trop Pediatr; 2010 Jun; 56(3):204-5. PubMed ID: 19748932
[No Abstract] [Full Text] [Related]
16. Clinical impact of antibiotic resistance in respiratory tract infections.
Klugman KP
Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S6-10. PubMed ID: 17307654
[TBL] [Abstract][Full Text] [Related]
17. [Surveillance of antimicrobial susceptibility of Streptococcus pneumoniae and Hemophilus influenzae isolated from children in Guangzhou area between 2003 and 2004].
Huang XQ; Xiao ZY; Deng L; Deng QL; Xie YQ; Yang YH
Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):441-4. PubMed ID: 16836856
[TBL] [Abstract][Full Text] [Related]
18. Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae.
Woodnutt G; Berry V
Antimicrob Agents Chemother; 1999 Jan; 43(1):29-34. PubMed ID: 9869561
[TBL] [Abstract][Full Text] [Related]
19. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention.
Harwell JI; Brown RB
Chest; 2000 Feb; 117(2):530-41. PubMed ID: 10669700
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary.
Nagy E; Marton A; Hajdú E
Acta Microbiol Immunol Hung; 2003; 50(2-3):119-24. PubMed ID: 12894483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
